PortalPublikationenClinical impact of GATA2 mutations in acute myeloid leukemia...

Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group (AMLSG)

Standard

Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group (AMLSG). / Theis, F; Corbacioglu, A; Gaidzik, V I; Paschka, P; Weber, D; Bullinger, L; Heuser, M; Ganser, A; Thol, F; Schlegelberger, B; Göhring, G; Köhne, C-H; Germing, U; Brossart, P; Horst, H-A; Haase, D; Götze, K; Ringhoffer, M; Fiedler, W; Nachbaur, D; Kindler, T; Held, G; Lübbert, M; Wattad, M; Salih, H R; Krauter, J; Schlenk, R F; Döhner, K.

in: LEUKEMIA, Jahrgang 30, Nr. 11, 11.2016, S. 2248-2250.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung

Harvard

Theis, F, Corbacioglu, A, Gaidzik, VI, Paschka, P, Weber, D, Bullinger, L, Heuser, M, Ganser, A, Thol, F, Schlegelberger, B, Göhring, G, Köhne, C-H, Germing, U, Brossart, P, Horst, H-A, Haase, D, Götze, K, Ringhoffer, M, Fiedler, W, Nachbaur, D, Kindler, T, Held, G, Lübbert, M, Wattad, M, Salih, HR, Krauter, J, Schlenk, RF & Döhner, K 2016, 'Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group (AMLSG)', LEUKEMIA, Jg. 30, Nr. 11, S. 2248-2250. https://doi.org/10.1038/leu.2016.185

APA

Theis, F., Corbacioglu, A., Gaidzik, V. I., Paschka, P., Weber, D., Bullinger, L., Heuser, M., Ganser, A., Thol, F., Schlegelberger, B., Göhring, G., Köhne, C-H., Germing, U., Brossart, P., Horst, H-A., Haase, D., Götze, K., Ringhoffer, M., Fiedler, W., ... Döhner, K. (2016). Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group (AMLSG). LEUKEMIA, 30(11), 2248-2250. https://doi.org/10.1038/leu.2016.185

Vancouver

Theis F, Corbacioglu A, Gaidzik VI, Paschka P, Weber D, Bullinger L et al. Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group (AMLSG). LEUKEMIA. 2016 Nov;30(11):2248-2250. https://doi.org/10.1038/leu.2016.185

Bibtex

@article{2eb3c4850d1b4083b224ec81b1446993,
title = "Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group (AMLSG)",
abstract = "Leukemia accepted article preview online, 04 July 2016. doi:10.1038/leu.2016.185.",
author = "F Theis and A Corbacioglu and Gaidzik, {V I} and P Paschka and D Weber and L Bullinger and M Heuser and A Ganser and F Thol and B Schlegelberger and G G{\"o}hring and C-H K{\"o}hne and U Germing and P Brossart and H-A Horst and D Haase and K G{\"o}tze and M Ringhoffer and W Fiedler and D Nachbaur and T Kindler and G Held and M L{\"u}bbert and M Wattad and Salih, {H R} and J Krauter and Schlenk, {R F} and K D{\"o}hner",
note = "Letters to the Editor",
year = "2016",
month = nov,
doi = "10.1038/leu.2016.185",
language = "English",
volume = "30",
pages = "2248--2250",
journal = "LEUKEMIA",
issn = "0887-6924",
publisher = "NATURE PUBLISHING GROUP",
number = "11",

}

RIS

TY - JOUR

T1 - Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group (AMLSG)

AU - Theis, F

AU - Corbacioglu, A

AU - Gaidzik, V I

AU - Paschka, P

AU - Weber, D

AU - Bullinger, L

AU - Heuser, M

AU - Ganser, A

AU - Thol, F

AU - Schlegelberger, B

AU - Göhring, G

AU - Köhne, C-H

AU - Germing, U

AU - Brossart, P

AU - Horst, H-A

AU - Haase, D

AU - Götze, K

AU - Ringhoffer, M

AU - Fiedler, W

AU - Nachbaur, D

AU - Kindler, T

AU - Held, G

AU - Lübbert, M

AU - Wattad, M

AU - Salih, H R

AU - Krauter, J

AU - Schlenk, R F

AU - Döhner, K

N1 - Letters to the Editor

PY - 2016/11

Y1 - 2016/11

N2 - Leukemia accepted article preview online, 04 July 2016. doi:10.1038/leu.2016.185.

AB - Leukemia accepted article preview online, 04 July 2016. doi:10.1038/leu.2016.185.

U2 - 10.1038/leu.2016.185

DO - 10.1038/leu.2016.185

M3 - Other (editorial matter etc.)

C2 - 27375010

VL - 30

SP - 2248

EP - 2250

JO - LEUKEMIA

JF - LEUKEMIA

SN - 0887-6924

IS - 11

ER -